{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:44:28Z","timestamp":1789152268434,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.metabol.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T13:10:12Z","timestamp":1421932212000},"page":"476-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["New Aspects on the Metabolic role of Intestinal Microbiota in the Development of Atherosclerosis"],"prefix":"10.1016","volume":"64","author":[{"given":"Ioannis","family":"Drosos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7995-0177","authenticated-orcid":false,"given":"Anna","family":"Tavridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5717","key":"10.1016\/j.metabol.2015.01.007_bb0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"Backhed","year":"2005","journal-title":"Science"},{"issue":"9356","key":"10.1016\/j.metabol.2015.01.007_bb0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","article-title":"Gut flora in health and disease","volume":"361","author":"Guarner","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.metabol.2015.01.007_bb0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrgastro.2012.152","article-title":"The gut microbiota in IBD","volume":"9","author":"Manichanh","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2015.01.007_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10620-012-2334-x","article-title":"Probiotic\/synbiotic therapy for treating critically ill patients from a gut microbiota perspective","volume":"58","author":"Shimizu","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.metabol.2015.01.007_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-116-4-273","article-title":"Chronic chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study","volume":"116","author":"Saikku","year":"1992","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.metabol.2015.01.007_bb0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.105.579979","article-title":"Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease","volume":"113","author":"Ott","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2015.01.007_bb0040","first-page":"636893","article-title":"Periodontitis as a risk factor of atherosclerosis","volume":"2014","author":"Bartova","year":"2014"},{"issue":"1 Suppl.","key":"10.1016\/j.metabol.2015.01.007_bb0045","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1136\/gut.35.1_Suppl.S28","article-title":"Clinical significance of translocation","volume":"35","author":"Van Leeuwen","year":"1994","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.metabol.2015.01.007_bb0050","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","article-title":"Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study","volume":"34","author":"Wiedermann","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.metabol.2015.01.007_bb0055","doi-asserted-by":"crossref","first-page":"e105221","DOI":"10.1371\/journal.pone.0105221","article-title":"Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation","volume":"9","author":"Dinakaran","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.metabol.2015.01.007_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.carpath.2012.03.001","article-title":"Cardiovascular risk and atherosclerosis prevention","volume":"22","author":"Frohlich","year":"2013","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"10.1016\/j.metabol.2015.01.007_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5223\/pghn.2013.16.1.22","article-title":"Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease","volume":"16","author":"Park","year":"2013","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"3","key":"10.1016\/j.metabol.2015.01.007_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12263-011-0230-1","article-title":"Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?","volume":"6","author":"Conterno","year":"2011","journal-title":"Genes Nutr"},{"issue":"7415","key":"10.1016\/j.metabol.2015.01.007_bb0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2015.01.007_bb0080","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-12-0498","article-title":"Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin","volume":"216","author":"Piya","year":"2013","journal-title":"J Endocrinol"},{"issue":"9","key":"10.1016\/j.metabol.2015.01.007_bb0085","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"issue":"7122","key":"10.1016\/j.metabol.2015.01.007_bb0090","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"issue":"7122","key":"10.1016\/j.metabol.2015.01.007_bb0095","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.metabol.2015.01.007_bb0100","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"10.1016\/j.metabol.2015.01.007_bb0105","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5728","key":"10.1016\/j.metabol.2015.01.007_bb0110","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.metabol.2015.01.007_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ijo.2012.33","article-title":"The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population","volume":"37","author":"Fava","year":"2013","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.metabol.2015.01.007_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02113-14","article-title":"Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis","volume":"5","author":"Kumar","year":"2014","journal-title":"MBio"},{"issue":"11","key":"10.1016\/j.metabol.2015.01.007_bb0125","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/ijo.2008.155","article-title":"Human colonic microbiota associated with diet, obesity and weight loss","volume":"32","author":"Duncan","year":"2008","journal-title":"Int J Obes (Lond)"},{"issue":"5975","key":"10.1016\/j.metabol.2015.01.007_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.metabol.2015.01.007_bb0135","doi-asserted-by":"crossref","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"issue":"7464","key":"10.1016\/j.metabol.2015.01.007_bb0140","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2015.01.007_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/gmic.26749","article-title":"Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease","volume":"5","author":"Brugere","year":"2014","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.metabol.2015.01.007_bb0150","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2013.10.013","article-title":"Gut microbiota metabolism of l-carnitine and cardiovascular risk","volume":"231","author":"Ussher","year":"2013","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.metabol.2015.01.007_bb0155","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjcard.2009.04.047","article-title":"Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome","volume":"104","author":"LeLeiko","year":"2009","journal-title":"Am J Cardiol"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2015.01.007_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cca.2007.05.001","article-title":"Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications","volume":"383","author":"Danne","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.metabol.2015.01.007_bb0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1373\/clinchem.2004.046292","article-title":"Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome","volume":"51","author":"Apple","year":"2005","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.metabol.2015.01.007_bb0170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atherosclerosis.2012.07.032","article-title":"Egg yolk consumption and carotid plaque","volume":"224","author":"Spence","year":"2012","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.metabol.2015.01.007_bb0175","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","article-title":"Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide","volume":"35","author":"Wang","year":"2014","journal-title":"Eur Heart J"},{"issue":"7341","key":"10.1016\/j.metabol.2015.01.007_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.metabol.2015.01.007_bb0185","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.metabol.2015.01.007_bb0190","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/004982597239949","article-title":"Metabolic disposition of [14C]-trimethylamine N-oxide in rat: variation with dose and route of administration","volume":"27","author":"Mitchell","year":"1997","journal-title":"Xenobiotica"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2015.01.007_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jchromb.2006.09.015","article-title":"Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography\u2013mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease","volume":"851","author":"Tsikas","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"10.1016\/j.metabol.2015.01.007_bb0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2009.01.040","article-title":"1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters","volume":"206","author":"Martin","year":"2009","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.metabol.2015.01.007_bb0205","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1172\/JCI35111","article-title":"Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury","volume":"118","author":"Lewis","year":"2008","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.metabol.2015.01.007_bb0210","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.metabol.2015.01.007_bb0215","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","article-title":"l-Carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"88","author":"DiNicolantonio","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.metabol.2015.01.007_bb0220","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.CIR.87.3.972","article-title":"Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation","volume":"87","author":"Broderick","year":"1993","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.metabol.2015.01.007_bb0225","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1074\/jbc.M109.032888","article-title":"Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control","volume":"284","author":"Noland","year":"2009","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.metabol.2015.01.007_bb0230","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmet.2012.04.005","article-title":"Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility","volume":"15","author":"Muoio","year":"2012","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.metabol.2015.01.007_bb0235","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.numecd.2014.03.007","article-title":"Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies","volume":"24","author":"Johri","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2015.01.007_bb0240","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat Commun"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2015.01.007_bb0245","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1011383107","article-title":"Human oral, gut, and plaque microbiota in patients with atherosclerosis","volume":"108","author":"Koren","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.01.007_bb0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/msb4100190","article-title":"Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model","volume":"4","author":"Martin","year":"2008","journal-title":"Mol Syst Biol"},{"issue":"4","key":"10.1016\/j.metabol.2015.01.007_bb0255","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5009\/gnl.2012.6.4.411","article-title":"Dietary Factors: Major Regulators of the Gut's Microbiota","volume":"6","author":"Moschen","year":"2012","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.metabol.2015.01.007_bb0260","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2013.05.019","article-title":"Gut microbiota: an environmental risk factor for cardiovascular disease","volume":"229","author":"Stock","year":"2013","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.metabol.2015.01.007_bb0265","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-2952(99)00166-5","article-title":"In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles","volume":"58","author":"Cashman","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2015.01.007_bb0270","first-page":"27","article-title":"Experimental approaches to studies on drug metabolism and drug interactions in man: interaction of acyclic nucleoside phosphonates with human liver cytochromes P450 and flavin-containing monooxygenase 3","volume":"27","author":"Matal","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"10.1016\/j.metabol.2015.01.007_bb0275","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/14622416.8.6.635","article-title":"Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives","volume":"8","author":"Hisamuddin","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.metabol.2015.01.007_bb0280","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/ATVBAHA.114.303252","article-title":"Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and l-carnitine","volume":"34","author":"Hartiala","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.metabol.2015.01.007_bb0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lfs.2014.09.028","article-title":"Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting l-carnitine microbial degradation","volume":"117","author":"Kuka","year":"2014","journal-title":"Life Sci"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:05:47Z","timestamp":1758427547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0026049515000220"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.01.007","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Aspects on the Metabolic role of Intestinal Microbiota in the Development of Atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}